© 1969 American Heart Association, Inc.
Influence of Deformability of Human Red Cells upon Blood Viscosity
1 Departments of Medicine, Harvard Medical School and Peter Bent Brigham Hospital Boston, Massachusetts 02115
The viscosity of blood at high rates of shear is unusually low compared to other suspensions of similar concentration. The underlying mechanisms were studied by rotational viscometry, red cell filtration, viscometry of packed cells and direct microscopic observation of red cells under flow in a transparent cone plate viscometer. Deformability of red cells was altered osmotically or abolished by aldehyde fixation. The normal red cells under isosmotic conditions passed easily through filter pores (5 to 14 µ diameter). After osmotic crenation, deformability of cells in pore flow was reduced. Normal cells were deformed into a variety of shapes at high rates of shear, while crenated cells tumbled undeformed. Suspensions of these normal cells showed more pronounced shear thinning (reduction of viscosity with increasing shear rate) than suspensions of crenated cells. Suspensions of rigid cells showed greatly increased viscosity and a shear thickening as a function of shear rate and shear time. The physiological deformability is of critical importance to blood flow at high rates of shear. This is possible through a fluid transition of the erythrocyte caused by a rotation of the membrane with and around the cell contents. This phenomenon is the prime cause of the progressive reduction in viscosity with increasing shear.
Key Words: capillary blood flow • erythrocyte membrane rheology • shear thinning at high shear rate • fluid transition of red cells • non-Newtonian viscosity of blood • suspension rheology
Submitted on March 17, 1969
Accepted on June 4, 1969
This article has been cited by other articles:
 |
|
 |
|
  C. S. Broberg, B. E. Bax, D. O. Okonko, M. W. Rampling, S. Bayne, C. Harries, S. J. Davidson, A. Uebing, A. A. Khan, S. Thein, et al. Blood Viscosity and its Relationship to Iron Deficiency, Symptoms, and Exercise Capacity in Adults With Cyanotic Congenital Heart Disease J. Am. Coll. Cardiol., July 18, 2006; 48(2): 356 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Dawson, Qintian Zheng, S. A. Worthy, B. Charles, and D. V. Bradley Failure of Pentoxifylline or Cilostazol to Improve Blood and Plasma Viscosity, Fibrinogen, and Erythrocyte Deformability in Claudication Angiology, September 1, 2002; 53(5): 509 - 520. [Abstract] [PDF]
|
|
|
|
 |
|
 J. K. Perloff, M. H. Rosove, J. S. Child, and G. B. Wright Adults with Cyanotic Congenital Heart Disease: Hematologic Management Ann Intern Med, September 1, 1988; 109(5): 406 - 413. [Abstract] [PDF]
|
|
|
|
|
|
A. Strano, G. Davi, G. Avellone, S. Novo, and A. Pinto Double-Blind, Crossover Study of the Clinical Efficacy and the Hemorheological Effects of Pentoxifylline in Patients With Occlusive Arterial Disease of the Lower Limbs Angiology, July 1, 1984; 35(7): 459 - 466. [Abstract] [PDF]
|
|
|
|
|
|
H. Schmid-Schonbein, H. Rieger, and T. Fischer Blood Fluidity as a Consequence of Red Cell Fluidity: Flow Properties of Blood and Flow Behavior of Blood in Vascular Diseases Angiology, May 1, 1980; 31(5): 301 - 319. [Abstract] [PDF]
|
|
|
|
 |
|
 P. P. Klug, L. S. Lessin, and P. Radice Rheological Aspects of Sickle Cell Disease Arch Intern Med, April 1, 1974; 133(4): 577 - 590. [Abstract] [PDF]
|
|
|
|
 |
|
 C. M. Cottrill and S. Kaplan Cerebral Vascular Accidents in Cyanotic Congenital Heart Disease Arch Pediatr Adolesc Med, April 1, 1973; 125(4): 484 - 487. [Abstract] [PDF]
|
|